Annexon's Stock Drop: Balancing Capital Raising & Shareholder Value
Update: 2025-11-12
Description
Annexons Stock Drops as Plans to Raise $75M Through Public OfferingBiopharmaceutical company Annexon, specializing in neuroinflammation treatments, announced plans to raise $75M through a public offering, causing a 6.7% drop in after-hours trading. The company aims to offer common stock or pre-funded warrants, with underwriters having a 30-day option to buy extra $11.25M in common stock. This move may dilute existing shareholders ownership, leading to market caution. The offering is subject to market conditions and no guarantee of completion.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
